First Trust Advisors’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-34,010
Closed -$828K 2453
2022
Q3
$828K Buy
34,010
+24,294
+250% +$836K ﹤0.01% 2065
2022
Q2
$301K Sell
9,716
-31,364
-76% -$834K ﹤0.01% 2302
2022
Q1
$1.43M Sell
41,080
-25,088
-38% -$949K ﹤0.01% 1909
2021
Q4
$3.92M Sell
66,168
-23,048
-26% -$1.59M ﹤0.01% 1491
2021
Q3
$5.93M Buy
89,216
+33,016
+59% +$2.04M 0.01% 1210
2021
Q2
$3.55M Sell
56,200
-3,027
-5% -$170K ﹤0.01% 1565
2021
Q1
$3.08M Sell
59,227
-834
-1% -$50.7K ﹤0.01% 1538
2020
Q4
$2.63M Buy
+60,061
New +$2.86M ﹤0.01% 1440

Other funds holding CYRX

First Trust Advisors's CYRX Position: Q4 2022 in Review

First Trust Advisors sold out of CryoPort (CYRX) in Q4 2022, closing a stake of 34,010 shares — an estimated $828K sold.

First Trust Advisors first reported a position in CYRX in Q4 2020 and held it in 8 quarters. The position peaked at $5.93M in Q3 2021. 171 funds tracked by Wall St. Rank hold CYRX as of Q4 2022.

  • First Trust Advisors reported no remaining CryoPort position as of Q4 2022 after selling out during the quarter.
  • First Trust Advisors sold 34,010 CryoPort shares in Q4 2022, an estimated $828K.
  • First Trust Advisors first reported a position in CryoPort in Q4 2020 and held it in 8 quarters.
  • First Trust Advisors's CryoPort position peaked at $5.93M in Q3 2021.
  • 171 funds tracked by Wall St. Rank held CryoPort as of Q4 2022.

Based on First Trust Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.